|
KR20150066782A
|
|
Method of preparing 1-(indolin-5-yl)propan-2-ol derivatives
|
|
KR20150066777A
|
|
Indoline derivatives and method of preparing the same
|
|
KR20120105744A
|
|
Process for preparing 3,4-dihydroquinazoline derivative and intermediate therefor
|
|
KR20120105739A
|
|
3,4-dihydroquinazoline dihydrochloride and anti-cancer agent including the same
|
|
KR20120103933A
|
|
The new process for the preparation of paliperidone intermediates (2,4-difluorophenyl)-piperidinyl-methanone hydrochloride
|
|
KR20130008661A
|
|
The new cystal form and a process of valacyclovir hydrochloride
|
|
KR20100039837A
|
|
Process for preparing of 2'-deoxy-2'2'-difluorocytidine
|
|
KR20110066318A
|
|
The new cystal form of rosiglitazone hydrochloride and thereof process for the preparation
|
|
KR20100019674A
|
|
Process for preparing highly pure rebamipide
|
|
KR20100007008A
|
|
New process for preparing terbinafine free base
|
|
KR20100000078A
|
|
Process for preparing docetaxel trihydrate
|
|
KR20090112980A
|
|
Method of preparing methylisogerambullone and intermediates therefor
|
|
KR20090110000A
|
|
Oral formulation of rosiglitazone using nanoparticles and preparation method for the same
|
|
KR20090101758A
|
|
Drug composition of polymer micelle and preparation method thereof
|
|
EP2139884A1
|
|
Process for preparing of 2'-deoxy-2'2'-difluorocytidine
|
|
KR20080022569A
|
|
Process for preparing lercanidipine hydrochloride
|
|
KR20090085808A
|
|
Method of preparing methylgerambullone and intermediates therefor
|
|
KR20090061840A
|
|
Process for preparing of 2'-deoxy-2'2'-difluorocytidine
|
|
KR20090061127A
|
|
Process for preparing pantoprazole sodium sesquihydrate
|
|
KR20090059635A
|
|
Process for preparing risedronate sodium as anhydrous and hydrate forms
|
